149 related articles for article (PubMed ID: 14757314)
1. Inhibitory effect of tellimagrandin I on chemically induced differentiation of human leukemia K562 cells.
Yi Z; Wang Z; Li H; Liu M
Toxicol Lett; 2004 Mar; 147(2):109-19. PubMed ID: 14757314
[TBL] [Abstract][Full Text] [Related]
2. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
3. Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin.
Terui K; Takahashi Y; Kitazawa J; Toki T; Yokoyama M; Ito E
Tohoku J Exp Med; 2000 Dec; 192(4):259-73. PubMed ID: 11286316
[TBL] [Abstract][Full Text] [Related]
4. Phenolic metabolites of benzene inhibited the erythroid differentiation of K562 cells.
Wu XR; Xue M; Li XF; Wang Y; Wang J; Han QL; Yi ZC
Toxicol Lett; 2011 Jun; 203(3):190-9. PubMed ID: 21414390
[TBL] [Abstract][Full Text] [Related]
5. Time-course of butyric acid-induced differentiation in human K562 leukemic cell line: rapid increase in gamma-globin, porphobilinogen deaminase and NF-E2 mRNA levels.
Chénais B; Molle I; Trentesaux C; Jeannesson P
Leukemia; 1997 Sep; 11(9):1575-9. PubMed ID: 9305615
[TBL] [Abstract][Full Text] [Related]
6. Requirement of GATA-1 and p45 NF-E2 expression in butyric acid-induced erythroid differentiation.
Chénais B
Biochem Biophys Res Commun; 1998 Dec; 253(3):883-6. PubMed ID: 9918824
[TBL] [Abstract][Full Text] [Related]
7. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis.
Labbaye C; Valtieri M; Barberi T; Meccia E; Masella B; Pelosi E; Condorelli GL; Testa U; Peschle C
J Clin Invest; 1995 May; 95(5):2346-58. PubMed ID: 7738198
[TBL] [Abstract][Full Text] [Related]
8. Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone.
Li Y; Wu XR; Li XF; Suriguga ; Yu CH; Li YR; Yi ZC
Toxicology; 2013 Oct; 312():108-14. PubMed ID: 23973255
[TBL] [Abstract][Full Text] [Related]
9. Expression of transcription factors during sodium phenylacetate induced erythroid differentiation in K562 cells.
Rath AV; Schmahl GE; Niemeyer CM
Blood Cells Mol Dis; 1997; 23(1):27-38. PubMed ID: 9215748
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of the two alternative promoters of human p45 NF-E2 gene.
Toki T; Arai K; Terui K; Komatsu N; Yokoyama M; Katsuoka F; Yamamoto M; Ito E
Exp Hematol; 2000 Oct; 28(10):1113-9. PubMed ID: 11027829
[TBL] [Abstract][Full Text] [Related]
11. Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1.
Ishiko E; Matsumura I; Ezoe S; Gale K; Ishiko J; Satoh Y; Tanaka H; Shibayama H; Mizuki M; Era T; Enver T; Kanakura Y
J Biol Chem; 2005 Feb; 280(6):4929-39. PubMed ID: 15563463
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation.
Ikonomi P; Rivera CE; Riordan M; Washington G; Schechter AN; Noguchi CT
Exp Hematol; 2000 Dec; 28(12):1423-31. PubMed ID: 11146164
[TBL] [Abstract][Full Text] [Related]
13. The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation.
Dupont C; Couillerot E; Gillet R; Caron C; Zeches-Hanrot M; Riou JF; Trentesaux C
Planta Med; 2005 Jun; 71(6):489-94. PubMed ID: 15971117
[TBL] [Abstract][Full Text] [Related]
14. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C
Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880
[TBL] [Abstract][Full Text] [Related]
15. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells.
Morceau F; Chénais B; Gillet R; Jardillier JC; Jeannesson P; Trentesaux C
Cell Growth Differ; 1996 Aug; 7(8):1023-9. PubMed ID: 8853898
[TBL] [Abstract][Full Text] [Related]
17. Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.
Solomon WB; Lin CH; Palma J; Gao XY; Wu S
J Biol Chem; 1993 Mar; 268(7):5089-96. PubMed ID: 8444885
[TBL] [Abstract][Full Text] [Related]
18. A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells.
Berkovitch-Luria G; Yakobovitch S; Weitman M; Nudelman A; Rozic G; Rephaeli A; Malik Z
Eur J Pharm Sci; 2012 Aug; 47(1):206-14. PubMed ID: 22705251
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
20. Erythroid properties of K562 cells. Effect of hemin, butyrate and TPA induction.
Villeval JL; Pelicci PG; Tabilio A; Titeux M; Henri A; Houesche F; Thomopoulos P; Vainchenker W; Garbaz M; Rochant H; Breton-Gorius J; Edwards PA; Testa U
Exp Cell Res; 1983 Jul; 146(2):428-35. PubMed ID: 6575918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
